Rotavirus DNA vaccine

Drug Profile

Rotavirus DNA vaccine

Latest Information Update: 16 Feb 2005

Price : $50

At a glance

  • Originator Health Protection Agency Porton Down; Nonindustrial source; Stanford University School of Medicine; University of Massachusetts Medical School
  • Developer Nonindustrial source
  • Class Gene therapies; Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Rotavirus infections

Most Recent Events

  • 16 Feb 2005 Discontinued - Preclinical for Rotavirus infections in USA (PO)
  • 24 Aug 1998 Preclinical development for Rotavirus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top